PortViewPortView
Intersect ENT logo

Intersect ENT (XENT) Stock Analysis

NASDAQHealthcareMedical - Devices

$28.24+0.00%
1-year price historyRange $26.77 – $28.24
52-week range$28.24
$15.92$28.25

Track XENT in your portfolio for free · Portfolio tracker

What Intersect ENT does

Intersect ENT, Inc. is a medical technology firm focused on ear, nose, and throat (ENT) solutions, operating within the United States. Its product portfolio includes: PROPEL, PROPEL Mini, and PROPEL Contour: These are steroid-eluting implants. PROPEL is designed to maintain the patency of surgically enlarged sinuses, while PROPEL Mini targets patients undergoing frontal sinus procedures. PROPEL Contour specifically addresses the frontal and maxillary sinus ostia, or passages, within the dependent sinuses. SINUVA: Another steroid-releasing implant, intended for patient care in a clinical office environment. VENSURE Navigable and Stand-alone balloon: A sterile, single-use balloon device that facilitates access to and treatment of the frontal, sphenoid, and maxillary ostia in adult patients via a trans-nasal method. CUBE Navigation System: A digital guidance system offering high-accuracy navigation for ENT and associated skull-base surgical interventions. The company, originally established as Sinexus, Inc. in 2003, rebranded to Intersect ENT, Inc. in November 2009. Its corporate headquarters are located in Menlo Park, California.

Key metrics

Market cap
$0
P/E (TTM)
-10.54
EPS (TTM)
$-2.68
Beta
1.53
Dividend yield
0.00%
Revenue / share
$3.21
50-day avg
$27.83
200-day avg
$27.38
52-week high
$28.25
52-week low
$15.92
CEO
Thomas West

ETFs linked to XENT

Broad-market and Healthcare sector ETFs an investor holding Intersect ENT is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how XENT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze XENT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Intersect ENT?
Intersect ENT trades under the ticker XENT on NASDAQ.
Which exchange is XENT listed on?
XENT is listed on NASDAQ.
What sector does Intersect ENT operate in?
Intersect ENT is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze XENT in a portfolio?
PortView shows XENT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.